
Professor Stephane Heymans
Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
Membership:
FESC Member
HFA Member
Biography
Cardiologist and Research Scientist since 2003 focusing on the molecular mechanisms of heart failure, looking at the interplay between inflammatory cells, fibroblasts and cardiomyocytes. Unraveled the key role of structural and non-structural matrix proteins and RNAs, including microRNAs, matrix metalloproteinases, collagens and matri-cellular proteins, in mediating cardiac inflammation, fibrosis and dysfunction.
His heart failure research focuses on heart with preserved ejection fraction (HFPEF) and dilated cardiomyopathies (DCM) (www.hfresearch.eu)SH is acknowledged for developing a clinical care program and related cohorts of non-ischemic CMP, myocarditis and HFPEF patients at the MUMC (> 1400 patients cohort and biobank of HFPEF and DCM patients with > 12 yrs FU). His program brings together immunologists, microbiologists, geneticians and molecular cardiologists to study the role of genetics, viruses, inflammation and other environmental factors in cardiomyopathies.
Contributor content
Session
Risk factors and comorbidities
12 May 2026
Session
Inflammation in heart failure: from mechanisms to therapies
11 May 2026
Session
Vaccination as the fourth pillar of cardiovascular care: the case for COVID-19
10 May 2026
Session
Inflammation in heart failure
19 May 2025
Session
The hidden burden of COVID-19 in cardiovascular patients: It's time for a rethink
18 May 2025
Session
Myofilaments in heart failure
21 January 2025
Session
COVID-19 and cardiovascular disease: rising to the challenge
1 September 2024
Session
Gene editing and gene therapies to cure cardiovascular diseases
31 August 2024
Session
Next generation heart failure therapies
11 May 2024
Session
Valvular disease and myocardial remodelling: a dangerous liaison
28 August 2023

